Suraksha Diagnostic Limited Stock: price and insider trades · India
No insider purchase over the last 90 days. The latest, by Aparajita Chatterjee, was filed 25 Feb 2026.
Suraksha Diagnostic Limited: what insiders have been doing
Suraksha Diagnostic Limited, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SEBI (PIT + SAST). Between 8 November 2025 and 8 November 2026, 3 insiders published 7 filings.
Every open-market trade in the period is a purchase: 7 purchases worth €157k, from 3 insiders, and not a single sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Those buying include 3 major shareholders. Biggest ticket of the year: €42k, bought by Aparajita Chatterjee and made public on 24 February 2026.
Across the 1,986 companies tracked on its exchange, the median is 4 filings; at 7 filings, this issuer sits above that mark. The full history, which starts in 2025, counts 17 purchases against no sales.
In the case of 2 purchases, another manager of the company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. The clock since the last published purchase (25 February 2026) now reads 256 days. Publication is fast: at least half of the trades appear on SEBI (PIT + SAST) on the same day. The shorter that gap, the sooner other investors can see what insiders have done.
Other companies in the same sector with recent insider buying flagged by our signals: Cooper Companies, Inc. and Cytosorbents Corp. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleSince the insiders bought
- +5.8%Entry ₹273.85 · Close at T+90 ₹289.60
- -8.2%Entry ₹281.20 · Close at T+90 ₹258.25
- -8.2%Entry ₹281.20 · Close at T+90 ₹258.25
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 9,000 shares@ ₹286.7317.4% of flowEquity SharesSEBI:89302a64f525adfe0bcf284be29f94c6c81e4764Canonical exit: 26 May 2026 (T+90)
- 6,234 shares@ ₹281.629911.8% of flowEquity SharesSEBI:e7b995ce3069a98b3490f115e7ccfd01cae751ecCanonical exit: 25 May 2026 (T+90)
- 15,809 shares@ ₹284.763730.1% of flowEquity SharesSEBI:bbf40ac85d9227a16afa3ce257d1d46417d938dcCanonical exit: 24 May 2026 (T+90)
- 11,044 shares@ ₹280.8620.9% of flowEquity SharesSEBI:815bbf3b31f1cf91dab19badd605058b11d4afaeCanonical exit: 21 May 2026 (T+90)
- 10,446 shares@ ₹279.8219.7% of flowEquity SharesSEBI:53c2e2362e98babb1eb17a7a449a261f217f0f19Canonical exit: 20 May 2026 (T+90)
- 5,800 shares@ ₹274.319723.3% of flowEquity SharesSEBI:ae71843e50aca140d030efdd466e3e1ab7edeed3Canonical exit: 9 Mar 2026 (T+90)
- 1,445 shares@ ₹274.69767.1% of flowEquity SharesSEBI:868b1b72e1b3f7c7eeb3c2a0ce7466de28c3c5d6Canonical exit: 9 Mar 2026 (T+90)
- 19,130 shares@ ₹301.6864100.0% of flowEquity SharesSEBI:74fec1e14febb45a459c077d10372bd425e5140cCanonical exit: 28 Dec 2025 (T+90)
- 7,800 shares@ ₹317.282114.1% of flowEquity SharesSEBI:2702af98ca8264693354de253dd169d7a7e13197Canonical exit: 16 Nov 2025 (T+90)
- 8,200 shares@ ₹302.405714.1% of flowEquity SharesSEBI:a94cb3263b821c9d17fe08edea73c81619691f36Canonical exit: 12 Nov 2025 (T+90)
- 8,235 shares@ ₹300.905814.1% of flowEquity SharesSEBI:d320b3eece4f4cba23e751aa7478f88802c83cb1Canonical exit: 11 Nov 2025 (T+90)
- 8,190 shares@ ₹302.531114.1% of flowEquity SharesSEBI:4861bc61828bfb8ad20e951cc4fa23dc8abdc617Canonical exit: 10 Nov 2025 (T+90)
- 7,450 shares@ ₹331.901914.3% of flowEquity SharesSEBI:fcdce8b8e80917842c656f82559feaf30cd1918fCanonical exit: 21 Sept 2025 (T+90)
- 15,275 shares@ ₹325.675992.9% of flowEquity SharesSEBI:d8910fcf5fb03f7927cfa6180752bef91aa11706Canonical exit: 17 Sept 2025 (T+90)
- 15,260 shares@ ₹326.141976.7% of flowEquity SharesSEBI:39534079e8ded69677792c529d06f97effb8fe30Canonical exit: 17 Sept 2025 (T+90)
- 7,615 shares@ ₹326.51114.6% of flowEquity SharesSEBI:57d128eae1430486c03495a23736533913c5876fCanonical exit: 16 Sept 2025 (T+90)
- 7,590 shares@ ₹327.410914.6% of flowEquity SharesSEBI:57041b52df1adaabb578559bec9f2620aacda8e8Canonical exit: 11 Sept 2025 (T+90)
17 of 17 declarations
About Suraksha Diagnostic Limited
Suraksha Diagnostic Limited is a company specializing in medical diagnostic services. It operates in the XBOM market and focuses on providing high-quality tests and analyses.
